Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer

The lack of a useful biomarker partly contributes to the increased mortality of non-small cell lung cancer (NSCLC). MiRNAs have become increasingly appreciated in diagnosis of NSCLC. In the present study, we used microarray to screen 2,549 miRNAs in serum samples from the training cohort (NSCLC, n =...

Full description

Bibliographic Details
Main Authors: Man Liu, Qiufang Si, Songyun Ouyang, Zhigang Zhou, Meng Wang, Chunling Zhao, Ting Yang, Yulin Wang, Xue Zhang, Wenbo Xie, Liping Dai, Jitian Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2020.597508/full
id doaj-2c9c502ec68a4eae892db448ec7a6494
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Man Liu
Man Liu
Qiufang Si
Qiufang Si
Songyun Ouyang
Zhigang Zhou
Meng Wang
Chunling Zhao
Ting Yang
Ting Yang
Yulin Wang
Yulin Wang
Xue Zhang
Xue Zhang
Wenbo Xie
Liping Dai
Liping Dai
Jitian Li
spellingShingle Man Liu
Man Liu
Qiufang Si
Qiufang Si
Songyun Ouyang
Zhigang Zhou
Meng Wang
Chunling Zhao
Ting Yang
Ting Yang
Yulin Wang
Yulin Wang
Xue Zhang
Xue Zhang
Wenbo Xie
Liping Dai
Liping Dai
Jitian Li
Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
Frontiers in Genetics
NSCLC
miR-4687-3p
microarray
bioinformatics
biomarker
author_facet Man Liu
Man Liu
Qiufang Si
Qiufang Si
Songyun Ouyang
Zhigang Zhou
Meng Wang
Chunling Zhao
Ting Yang
Ting Yang
Yulin Wang
Yulin Wang
Xue Zhang
Xue Zhang
Wenbo Xie
Liping Dai
Liping Dai
Jitian Li
author_sort Man Liu
title Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
title_short Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
title_full Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
title_fullStr Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
title_full_unstemmed Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
title_sort serum mir-4687-3p has potential for diagnosis and carcinogenesis in non-small cell lung cancer
publisher Frontiers Media S.A.
series Frontiers in Genetics
issn 1664-8021
publishDate 2020-11-01
description The lack of a useful biomarker partly contributes to the increased mortality of non-small cell lung cancer (NSCLC). MiRNAs have become increasingly appreciated in diagnosis of NSCLC. In the present study, we used microarray to screen 2,549 miRNAs in serum samples from the training cohort (NSCLC, n = 10; the healthy, n = 10) to discover differentially expressed miRNAs (DEMs). Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) assay was applied to validate the expression level of selected overexpressed DEMs of NSCLC in a validation cohort (NSCLC, n = 30; the healthy, n = 30). Area under the receiver operating characteristic curve (AUC) was performed to evaluate diagnostic capability of the DEMs. The expression of the miRNAs in tissues was analyzed based on the TCGA database. Subsequently, the target genes of the miR-4687-3p were predicted by TargetScan. Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were tested by R software (ClusterProfiler package). NSCLC cells were transfected with inhibitor or mimic to down-regulate or up-regulate the miR-4687-3p level. The function of miR-4687-3p on proliferation, invasion, and migration of lung cancer cells were investigated through CCK-8 and Transwell assays, respectively. In the results, we identified serum miR-4687-3p that provided a high diagnostic accuracy of NSCLC (AUC = 0.679, 95%CI: 0.543–0.815) in the validation cohort. According to the TCGA database, we found that the miR-4687-3p level was significantly higher in NSCLC tissues than in normal lung tissues (p < 0.05). GO and KEGG pathway enrichment analysis showed that postsynaptic specialization and TGF-β signaling pathway were significantly enriched. Down-regulation of miR-4687-3p could suppress the proliferation, invasion, and migration of the NSCLC cells, compared with inhibitor negative control (NC). Meanwhile, overexpression of miR-4687-3p could promote the proliferation, invasion, and migration of the NSCLC cells compared with mimic NC. As a conclusion, our study first discovered that serum miR-4687-3p might have clinical potential as a non-invasive diagnostic biomarker for NSCLC and play an important role in the development of NSCLC.
topic NSCLC
miR-4687-3p
microarray
bioinformatics
biomarker
url https://www.frontiersin.org/articles/10.3389/fgene.2020.597508/full
work_keys_str_mv AT manliu serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT manliu serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT qiufangsi serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT qiufangsi serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT songyunouyang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT zhigangzhou serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT mengwang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT chunlingzhao serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT tingyang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT tingyang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT yulinwang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT yulinwang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT xuezhang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT xuezhang serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT wenboxie serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT lipingdai serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT lipingdai serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
AT jitianli serummir46873phaspotentialfordiagnosisandcarcinogenesisinnonsmallcelllungcancer
_version_ 1724419924331331584
spelling doaj-2c9c502ec68a4eae892db448ec7a64942020-11-25T04:10:37ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-11-011110.3389/fgene.2020.597508597508Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung CancerMan Liu0Man Liu1Qiufang Si2Qiufang Si3Songyun Ouyang4Zhigang Zhou5Meng Wang6Chunling Zhao7Ting Yang8Ting Yang9Yulin Wang10Yulin Wang11Xue Zhang12Xue Zhang13Wenbo Xie14Liping Dai15Liping Dai16Jitian Li17Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Tumor Epidemiology & State Key Laboratory of Esophageal Cancer Prevention, Zhengzhou University, Zhengzhou, ChinaBGI College, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Tumor Epidemiology & State Key Laboratory of Esophageal Cancer Prevention, Zhengzhou University, Zhengzhou, ChinaDepartment of Respiratory and Sleep Medicine, The First Affiliated Hospital in Zhengzhou University, Zhengzhou, ChinaDepartment of Radiology, The First Affiliated Hospital in Zhengzhou University, Zhengzhou, ChinaDepartment of Radiology, The First Affiliated Hospital in Zhengzhou University, Zhengzhou, ChinaDepartment of Respiratory and Sleep Medicine, The First Affiliated Hospital in Zhengzhou University, Zhengzhou, ChinaBGI College, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Tumor Epidemiology & State Key Laboratory of Esophageal Cancer Prevention, Zhengzhou University, Zhengzhou, ChinaHenan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Tumor Epidemiology & State Key Laboratory of Esophageal Cancer Prevention, Zhengzhou University, Zhengzhou, ChinaHenan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Tumor Epidemiology & State Key Laboratory of Esophageal Cancer Prevention, Zhengzhou University, Zhengzhou, ChinaDepartment of Computer Science, College of Engineering, University of Texas at El Paso, El Paso, TX, United StatesHenan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory of Tumor Epidemiology & State Key Laboratory of Esophageal Cancer Prevention, Zhengzhou University, Zhengzhou, ChinaLaboratory of Molecular Biology, Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital), Zhengzhou, ChinaThe lack of a useful biomarker partly contributes to the increased mortality of non-small cell lung cancer (NSCLC). MiRNAs have become increasingly appreciated in diagnosis of NSCLC. In the present study, we used microarray to screen 2,549 miRNAs in serum samples from the training cohort (NSCLC, n = 10; the healthy, n = 10) to discover differentially expressed miRNAs (DEMs). Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) assay was applied to validate the expression level of selected overexpressed DEMs of NSCLC in a validation cohort (NSCLC, n = 30; the healthy, n = 30). Area under the receiver operating characteristic curve (AUC) was performed to evaluate diagnostic capability of the DEMs. The expression of the miRNAs in tissues was analyzed based on the TCGA database. Subsequently, the target genes of the miR-4687-3p were predicted by TargetScan. Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were tested by R software (ClusterProfiler package). NSCLC cells were transfected with inhibitor or mimic to down-regulate or up-regulate the miR-4687-3p level. The function of miR-4687-3p on proliferation, invasion, and migration of lung cancer cells were investigated through CCK-8 and Transwell assays, respectively. In the results, we identified serum miR-4687-3p that provided a high diagnostic accuracy of NSCLC (AUC = 0.679, 95%CI: 0.543–0.815) in the validation cohort. According to the TCGA database, we found that the miR-4687-3p level was significantly higher in NSCLC tissues than in normal lung tissues (p < 0.05). GO and KEGG pathway enrichment analysis showed that postsynaptic specialization and TGF-β signaling pathway were significantly enriched. Down-regulation of miR-4687-3p could suppress the proliferation, invasion, and migration of the NSCLC cells, compared with inhibitor negative control (NC). Meanwhile, overexpression of miR-4687-3p could promote the proliferation, invasion, and migration of the NSCLC cells compared with mimic NC. As a conclusion, our study first discovered that serum miR-4687-3p might have clinical potential as a non-invasive diagnostic biomarker for NSCLC and play an important role in the development of NSCLC.https://www.frontiersin.org/articles/10.3389/fgene.2020.597508/fullNSCLCmiR-4687-3pmicroarraybioinformaticsbiomarker